VAERS reports by lot

GSK Hepatitis A lot TB3KN: VAERS reports

28 VAERS reports list lot TB3KN as a GSK Hepatitis A vaccine, received between 2022-02-15 and 2023-12-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
4%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1627%
Neurological1322%
Gastrointestinal813%
Cardiac / Cardiovascular712%
Allergic / Anaphylactic47%
Musculoskeletal35%
Injection-site / Local reaction35%
Thrombotic / Hematological23%
Autoimmune / Immune-mediated12%
Respiratory12%
Dermatological (non-injection-site)12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Iowa4
Texas3
Massachusetts2
California2
Washington2
Pennsylvania1
Wyoming1
Alabama1
New Jersey1
New Mexico1
North Carolina1
Florida1

Reports by month received

2022-023
2022-032
2022-042
2022-051
2022-062
2022-071
2022-085
2022-101
2022-121
2023-026
2023-061
2023-081
2023-091
2023-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.